IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2026)
IceCure Medical's (ICCM) quarterly Cash from Investing Activities came in at -$10000.0 in Q2 2026, up 54.55% year-over-year from -$6470.6 in Q2 2025, and up 80.39% quarter-over-quarter from -$51000.0 in Q1 2026.
Analysis
IceCure Medical (ICCM) Cash from Investing Activities (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has reported Cash from Investing Activities for 7 consecutive years, with -$10000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 54.55% year-over-year to -$10000.0 in Q2 2026; TTM through Jun 2026 was -$69000.0, a 108.96% decrease from a year earlier, with the FY2025 full-year figure at -$36000.0, down 108.07% from the prior year.
- Cash from Investing Activities was -$10000.0 for Q2 2026 at IceCure Medical, up from -$51000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $8.7 million in Q4 2023 and troughed at -$15.1 million in Q1 2023.
- A 5-year average of -$68111.1 and a median of -$6500.0 in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 10400.0% in 2023 and surged 71457.14% in 2025, its largest moves.
- Over 5 years, Cash from Investing Activities stood at $1.7 million in 2022, then jumped by 419.99% to $8.7 million in 2023, then tumbled by 100.08% to -$7000.0 in 2024, then surged by 71457.14% to $5.0 million in 2025, then tumbled by 100.2% to -$10000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$10000.0 (Q2 2026), -$51000.0 (Q1 2026), and $5.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -108.50 Mn |
| 10 | IceCure Medical | 5.44 Mn | -6.60 Mn | 253,000.00 | -10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,000.00 |
| Mar 31, 2026 | -51,000.00 |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 805,000.00 |
| Jun 30, 2024 | -843,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | 8.72 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | -15.12 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | -4.63 Mn |
| Mar 31, 2022 | -144,000.00 |
| Dec 31, 2021 | -179,000.00 |
| Sep 30, 2021 | -108,000.00 |